We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+38.97%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$670M
AUM Growth
+$90.6M
(+16%)
Cap. Flow
-$42.2M
Cap. Flow
% of AUM
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
80
New
17
Increased
16
Reduced
32
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$40.5M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$14.7M |
| 3 |
Boston Scientific
BSX
|
+$12.4M |
| 4 |
Teleflex
TFX
|
+$10M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$9.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$21.9M |
| 2 |
Teladoc Health
TDOC
|
+$17.3M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$17.2M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$15M |
| 5 |
Novartis
NVS
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.45% |
| 2 | Industrials | 5.08% |
| 3 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cigna
CI
$79.6B
| $10.7M | 1.59% |
52,107
-10,306
| -17% | -$1.89M |
|
27
Merck
MRK
$326B
| $10.3M | 1.54% |
118,843
-4,402
| -4% | -$362K |
|
28
Alnylam Pharmaceuticals
ALNY
$38.5B
| $10.1M | 1.51% |
87,600
-96,741
| -52% | -$9.64M |
|
|
TRHC
29
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.1M | 1.5% |
207,182
+86,582
| +72% | +$4.05M |
|
|
CSII
30
DELISTED
Cardiovascular Systems, Inc.
CSII
| $10M | 1.49% |
+205,782
| New | +$9.37M |
|
31
Biogen
BIIB
$30.4B
| $9.66M | 1.44% |
+32,542
| New | +$9.03M |
|
32
iRhythm Holdings
IRTC
$3.86B
| $9.36M | 1.4% |
137,500
-50,250
| -27% | -$3.41M |
|
|
HMSY
33
DELISTED
HMS Holdings Corp.
HMSY
| $8.89M | 1.33% |
300,275
+222,550
| +286% | +$6.83M |
|
34
Eli Lilly
LLY
$1.09T
| $8.64M | 1.29% |
65,765
+10,000
| +18% | +$1.16M |
|
35
AstraZeneca
AZN
$267B
| $7.87M | 1.17% |
+78,900
| New | +$7.43M |
|
|
PRAH
36
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.77M | 1.16% |
+69,915
| New | +$7.19M |
|
37
Zimmer Biomet
ZBH
$18.5B
| $7.37M | 1.1% |
50,726
-17,870
| -26% | -$2.47M |
|
38
Sarepta Therapeutics
SRPT
$1.63B
| $7.32M | 1.09% |
56,760
-27,638
| -33% | -$2.79M |
|
39
NextCure
NXTC
$22.1M
| $7.04M | 1.05% |
+10,417
| New | +$5.23M |
|
|
SILK
40
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.87M | 1.03% |
+170,200
| New | +$5.96M |
|
41
Abbott
ABT
$187B
| $6.71M | 1% |
77,198
-10,000
| -11% | -$838K |
|
42
uniQure
QURE
$2.52B
| $6.27M | 0.94% |
87,500
+58,000
| +197% | +$3.18M |
|
43
Medtronic
MDT
$111B
| $6.26M | 0.93% |
55,151
-17,500
| -24% | -$1.92M |
|
44
Acadia Pharmaceuticals
ACAD
$4.45B
| $6.18M | 0.92% |
+144,450
| New | +$6.28M |
|
45
UnitedHealth
UNH
$389B
| $6.09M | 0.91% |
+20,721
| New | +$5.42M |
|
|
MTEM
46
DELISTED
Molecular Templates, Inc.
MTEM
| $6.05M | 0.9% |
28,839
+9,198
| +47% | +$1.32M |
|
|
CHNG
47
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $5.94M | 0.89% |
362,603
-43,147
| -11% | -$579K |
|
48
Amgen
AMGN
$212B
| $3.95M | 0.59% |
+16,403
| New | +$3.62M |
|
49
Thermo Fisher Scientific
TMO
$214B
| $3.82M | 0.57% |
11,750
-6,450
| -35% | -$1.96M |
|
|
BPMC
50
DELISTED
Blueprint Medicines
BPMC
| $3.6M | 0.54% |
+45,000
| New | +$3.37M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Sectoral Asset Management held 80 positions worth $670M, up 16% from $580M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sectoral Asset Management withdrew a net $42.2M in Q4 2019, closing 15 positions and reducing 32 holdings. Its most notable exit was Wright Medical Group Inc, an estimated $21.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.
Against the trend, Sectoral Asset Management opened a new position in Aprea Therapeutics worth $67.5M.
- Sectoral Asset Management's largest Q4 2019 buy was Aprea Therapeutics: 73,517 shares worth $67.5M.
- Sectoral Asset Management added most to Boston Scientific in Q4 2019, an estimated $12.4M increase.
- Sectoral Asset Management's biggest Q4 2019 reduction was Teladoc Health, cutting an estimated $17.3M.
- Sectoral Asset Management fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $21.9M.
- Sectoral Asset Management's ten largest holdings make up 37% of its $670M portfolio in Q4 2019.
- Sectoral Asset Management opened 17 new positions and closed 15 in Q4 2019.
- Sectoral Asset Management's portfolio value rose 16% quarter-over-quarter to $670M.
Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.